FNY Investment Advisers, LLC

Position in ATYR — aTYR PHARMA INC

CIK 1742998 NEW YORK, NY

Back to ATYR Full portfolio

Position in ATYR

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$895

+$894 QoQ

Shares Held

1,500

0.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#72

of 90 holders

Holding Since

Jun 2023

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATYR Over Time

Shares Held

Position Value (USD)

Derivatives in ATYR

reported options exposure · as of Jun 30, 2026

CallValue

CallShares

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FNY Investment Advisers, LLC holds $19,945,542 across 57 Biotechnology names. ATYR ranks #48 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1			108,951	$13,455,448
2	ABVX	Abivax S.A.	7,605	$1,013,442
3	SGMT	Sagimet Biosciences Inc.	109,250	$844,502
4	APGE	Apogee Therapeutics, Inc.	5,000	$663,650
5	JANX	Janux Therapeutics, Inc.	30,850	$473,856
6	NKTR	Nektar Therapeutics	5,500	$383,955
7	VERU	Veru Inc.	105,081	$328,903
8	VKTX	Viking Therapeutics, Inc.	8,170	$318,711

All Filings in ATYR

Export CSV

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8	15	0.0%	Put	Sole	2026-07-08
2026-06-30	$895	1,500	0.0%	Shares	Sole	2026-07-08
2026-03-31	$11	15	-68.8%	Put	Sole	2026-04-15
2026-03-31	$1	1,500	-68.8%	Shares	Sole	2026-04-15
2025-12-31	$3	4,800	+585.7%	Shares	Sole	2026-01-16
2025-12-31	$37	48	+585.7%	Put	Sole	2026-01-16
2025-09-30	$504	700	—	Shares	Sole	2025-12-15
2025-09-30	$5	7	—	Put	Sole	2025-12-15
2023-06-30	$6	3	—	Call	Sole	2023-07-11
No filing history on record for this holder in this stock.